Atlas Capital Advisors LLC Merck & Co., Inc. Transaction History

Atlas Capital Advisors LLC

$788 Billion
Q4 2024

A detailed history of Atlas Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 6,911 shares of MRK stock, worth $575,617. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,911

Previous 4,470 54.61%

Holding current value

$575,617

Previous $508 Million 35.44%

% of portfolio

0.09%

Previous 0.08%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$96.31 - $114.76 $235,092 - $280,129	2,441 Added 54.61%	6,911 $688 Million
Q3 2024 Nov 05, 2024	SELL	$111.15 - $128.97 $81,695 - $94,792	-735 Reduced 14.12%	4,470 $508 Million
Q2 2024 Jul 29, 2024	BUY	$123.8 - $132.96 $90,993 - $97,725	735 Added 16.44%	5,205 $644 Million
Q1 2024 Apr 15, 2024	SELL	$113.24 - $131.95 $83,231 - $96,983	-735 Reduced 14.12%	4,470 $590 Million
Q4 2023 Feb 15, 2024	SELL	$100.18 - $109.02 $127,829 - $139,109	-1,276 Reduced 19.69%	5,205 $567 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $14,001 - $15,548	-136 Reduced 2.06%	6,481 $667 Million
Q2 2023 Aug 15, 2023	SELL	$108.61 - $118.38 $51,046 - $55,638	-470 Reduced 6.63%	6,617 $764 Million
Q1 2023 May 16, 2023	SELL	$102.94 - $114.86 $345,775 - $385,814	-3,359 Reduced 32.16%	7,087 $754 Million
Q4 2022 Feb 15, 2023	BUY	$87.44 - $112.11 $348,098 - $446,309	3,981 Added 61.58%	10,446 $1.16 Billion
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $11,665 - $13,104	138 Added 2.18%	6,465 $557 Million
Q2 2022 Aug 16, 2022	SELL	$83.49 - $94.64 $115,884 - $131,360	-1,388 Reduced 17.99%	6,327 $577 Million
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $106,221 - $119,068	1,445 Added 23.05%	7,715 $633 Million
Q4 2021 Feb 01, 2022	BUY	$72.28 - $90.54 $159,955 - $200,365	2,213 Added 54.55%	6,270 $481 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $110,316 - $122,021	1,569 Added 63.06%	4,057 $315,000
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $178,563 - $198,169	2,488 New	2,488 $194,000
Q3 2020 Oct 23, 2020	SELL	$73.18 - $82.95 $182,071 - $206,379	-2,488 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$70.42 - $80.13 $70,420 - $80,130	-1,000 Reduced 28.67%	2,488 $183,000
Q1 2020 May 04, 2020	SELL	$63.36 - $87.82 $14,636 - $20,286	-231 Reduced 6.21%	3,488 $256,000
Q4 2019 Jan 28, 2020	SELL	$77.58 - $87.54 $6,051 - $6,828	-78 Reduced 2.05%	3,719 $322,000
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $21,454 - $23,386	282 Added 8.02%	3,797 $304,000
Q2 2019 Jul 25, 2019	BUY	$69.84 - $81.59 $141,984 - $165,872	2,033 Added 137.18%	3,515 $0
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $3,200 - $3,650	-46 Reduced 3.01%	1,482 $0
Q4 2018 Jan 29, 2019	BUY	$65.24 - $75.71 $9,981 - $11,583	153 Added 11.13%	1,528 $111,000
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $11,653 - $13,703	202 Added 17.22%	1,375 $0
Q1 2018 Apr 18, 2018	BUY	$50.96 - $59.23 $59,776 - $69,476	1,173 New	1,173 $0

Others Institutions Holding MRK

# of Institutions

3,947

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $211B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Merck & Co., Inc. Transaction History